PRM Proteome Sciences Plc

TIDMPRM

RNS Number : 9136M

Proteome Sciences PLC

26 May 2022

26 May 2022

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Change of Registered Office

The directors of Proteome Sciences announce that the Company's registered office address has changed to Coveham House, Downside Bridge Road, Cobham, Surrey KT11 3EP with immediate effect.

For further information:

 
 Proteome Sciences plc 
  Dr Mariola Soehngen, Chief Executive Officer & 
 Dr Ian Pike, Chief Scientific Officer   Tel: +44 (0)20 7043 2116 
 
   Allenby Capital Limited (AIM Nominated Adviser & Broker) 
 John Depasquale / Jeremy Porter         Tel: +44 (0) 20 3328 5656 
 

About Proteome Sciences plc. ( www.proteomics.com )

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant(R) and TMT(R)MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator(TM) provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.

The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROFIFITELIRFIF

(END) Dow Jones Newswires

May 26, 2022 04:04 ET (08:04 GMT)

Proteome Sciences (LSE:PRM)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024

Proteome Sciences (LSE:PRM)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024